Indefinite Delivery Contract 36C25726D0024
- Not listed
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs on November 1, 2025. The contract, valued at $500,000 ceiling with a guaranteed minimum of $1,000, extends through October 31, 2030, and provides chemotherapy preparation and compounding services for the Amarillo VA Medical Center in...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs Veterans Integrated Service Network 16 on October 15, 2025, with a ceiling value of $1.5 million and a performance period extending through September 30, 2030. This contract procures contingency hazardous compounded sterile pharmaceutical products services, specifically the aseptic compounding of chemotherapy agents for...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a single-award Indefinite Delivery Contract valued at $6.75M to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, for pharmacy hazardous compounding services. The contract period extends from October 1, 2024 through September 30, 2029, with no set-aside designation and full and open competition. The scope encompasses the preparation of specialized pharmaceutical...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a single-award Blanket Purchase Agreement with a $500,000 ceiling value to Optum Infusion Services 308, LLC (a subsidiary of UnitedHealth Group Incorporated) on August 24, 2021, with an ultimate completion date of August 23, 2026. The contract procures chemotherapy compound chemical mixes, which are specialized pharmaceutical preparations used to support oncology and cancer treatment services provided to...
- The Department of Veterans Affairs Veterans Health Administration awarded a single-award Blanket Purchase Agreement valued at $750,000.00 to Optum Infusion Services 308, LLC (a subsidiary of UnitedHealth Group Incorporated) on December 25, 2025, for the provision of contingency pharmacy compounding products and services. The contract, which runs through December 25, 2030, establishes an indefinite delivery vehicle for aseptically compounded hazardous chemotherapy agents and related...
- This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award contract, valued at up to $800,000, is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Optum Pharmacy, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services including the preparation of customized chemotherapy agents, hazardous...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated and operating as Avella Specialty Pharmacy, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs Veterans Integrated Service Network 17 on June 1, 2020, with a ceiling value of $10,000,000 and an ultimate completion date of October 31, 2025. This civilian contract, awarded through full and open competition with no set-aside designation, procures specialized pharmacy...
- This indefinite delivery contract was awarded by the Veterans Integrated Service Network 2, a civilian federal agency, to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $1,071,930.52 and a period of performance from October 1, 2025 to September 30, 2026. The contract is for chemo compounding services, with a single task order for $1,071,930.52 to provide these services. The place of performance is Chandler, Arizona. No...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Blanket Purchase Agreement (BPA) by Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs, on November 17, 2021. The contract, valued at $2.62 million with an ultimate completion date of November 16, 2026, encompasses chemotherapy compounding services and reflects a novation agreement resulting from a name change to Avella of Deer Valley, Inc....
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
- 36C25726D0024Indefinite Delivery Contract
- 1Federal Contract Awards
Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 17 (VISN 17) on November 1, 2025, to provide pharmacy compounding services for oncology drugs at the Dallas Veterans Affairs Healthcare System. The contract has a ceiling value of $6,000,000 and extends through October 31, 2030. The prime contractor will deliver chemotherapy preparation services to the North Texas VA Healthcare System, specifically serving the Dallas VA Medical Center and Garland VA Clinic located at 4500 S Lancaster Road, Dallas, Texas. Services include preparing chemotherapeutic medications based on orders from VA Oncologists or Hematologists, maintaining Joint Commission-compliant quality assurance standards, and delivering next-day prepared chemotherapy compounds from certified primary and secondary engineering control environments. The contractor must process orders during specified service hours, maintain comprehensive pharmaceutical inventory capabilities encompassing over 300 medical products including various chemotherapy drugs and IV solutions, provide daily shift reporting, and submit monthly activity reports in compliance with VA healthcare policies. The solicitation, issued on October 7, 2025, with responses due October 15, 2025, was evaluated as a competitive best-value acquisition considering technical capability, price, and past performance. The contract structure is a five-year Indefinite Delivery/Indefinite Quantity arrangement with a base period from November 1, 2025, through October 31, 2026, followed by four additional option years. The original solicitation established a minimum guaranteed value of $12,000 and a maximum aggregate value of $1,200,000; however, the awarded contract ceiling of $6,000,000 reflects the final negotiated value. No set-aside designations were utilized, and the award was made through open competition to a U.S.-based contractor capable of meeting rigorous pharmaceutical compounding and compliance requirements specific to VA oncology operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 10/27/25 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25726D0024-36C25726N0098 | Optum Infusion Services 308, LLC | $1.2m | 11/1/25 | 10/26/26 | 10/28/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Dallas Pharmacy Compounding Oncology NTX VA Healthcare System | 36C25726Q0033 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Award Notice 3/3 | 10/28/25, 4:47 PM | |
Q517--Dallas Pharmacy Compounding-Oncology | 36C25726D0024 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Award Notice 2/3 | 10/27/25, 10:23 AM | |
Q517--Dallas Pharmacy Compounding-Oncology | 36C25726Q0033 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Solicitation 1/3 | 10/7/25, 4:23 PM |